Aveo's Tivozanib kidney cancer drug will get the nod from regulators.
Beware market sages offering investment advice.
When it comes to investing, the right temperament is crucial.
After taking a beating, Bank of America's stock has staged an impressive comeback.
Bank of American could be a break-out financial play next year.
Another quarter has gone by
...and still no call from your broker
Try real-time communication and transparency
Danger always lies where there is a crowd. Today the crowd thinks safety is safe.
Across the board the relative safety profile of Tivo stands out.
You will sometimes be wrong even when you are right - and sometimes you will just be wrong.
Manager Chris Rees says he is holding tight to Argentina's YPF